Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,378,593
  • Shares Outstanding, K 48,902
  • Annual Sales, $ 644,400 K
  • Annual Income, $ 137,550 K
  • 60-Month Beta 0.82
  • Price/Sales 3.65
  • Price/Cash Flow 11.02
  • Price/Book 3.30
Trade AMPH with:

Options Overview Details

View History
  • Implied Volatility 41.58% ( +3.85%)
  • Historical Volatility 48.56%
  • IV Percentile 25%
  • IV Rank 36.60%
  • IV High 79.07% on 02/13/24
  • IV Low 19.94% on 09/10/24
  • Put/Call Vol Ratio 0.29
  • Today's Volume 58
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 1,821
  • Open Int (30-Day) 1,668

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.95
  • Number of Estimates 4
  • High Estimate 1.00
  • Low Estimate 0.87
  • Prior Year 1.08
  • Growth Rate Est. (year over year) -12.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.60 +14.17%
on 09/10/24
50.23 -0.90%
on 09/18/24
+4.82 (+10.72%)
since 08/16/24
3-Month
36.56 +36.16%
on 07/09/24
50.23 -0.90%
on 09/18/24
+9.73 (+24.29%)
since 06/18/24
52-Week
36.56 +36.16%
on 07/09/24
65.92 -24.49%
on 01/05/24
+3.55 (+7.68%)
since 09/18/23

Most Recent Stories

More News
Amphastar: Q2 Earnings Snapshot

Amphastar: Q2 Earnings Snapshot

AMPH : 49.78 (+2.34%)
Amphastar: Q1 Earnings Snapshot

Amphastar: Q1 Earnings Snapshot

AMPH : 49.78 (+2.34%)
Amphastar: Q4 Earnings Snapshot

Amphastar: Q4 Earnings Snapshot

AMPH : 49.78 (+2.34%)
Amphastar: Q3 Earnings Snapshot

Amphastar: Q3 Earnings Snapshot

AMPH : 49.78 (+2.34%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 62.31 (+0.61%)
KNSA : 25.27 (-0.47%)
ACAD : 16.33 (+0.43%)
HRMY : 38.34 (-1.21%)
AMPH : 49.78 (+2.34%)
INCY : 65.17 (-1.90%)
AGEN : 6.05 (-2.89%)
NVS : 115.97 (+0.23%)
PFE : 29.75 (-0.27%)
SGEN : 228.74 (-0.07%)
MRK : 118.64 (+0.30%)
RXDX : 199.92 (+0.09%)
Amphastar: Q2 Earnings Snapshot

Amphastar: Q2 Earnings Snapshot

AMPH : 49.78 (+2.34%)
Promising Small Biotech Amphastar Sees Actionable Pullback

Small-cap Amphastar Pharmaceuticals is pulling back from recent highs in an orderly fashion, potentially offering a new entry point after beating Q1 views.

AMPH : 49.78 (+2.34%)
LLY : 904.97 (-0.13%)
Amphastar: Q1 Earnings Snapshot

Amphastar: Q1 Earnings Snapshot

AMPH : 49.78 (+2.34%)
Lilly to Divest BAQSIMI to Amphastar

/PRNewswire/ -- In an effort to continue expanding the availability of BAQSIMI® to patients, Eli Lilly and Company (NYSE: LLY) and Amphastar Pharmaceuticals,...

LLY : 904.97 (-0.13%)
AMPH : 49.78 (+2.34%)
Why Shares of Amphastar Pharmaceuticals Rose Today

The company reported a record revenue year and increased EPS.

AMPH : 49.78 (+2.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

3rd Resistance Point 52.50
2nd Resistance Point 51.37
1st Resistance Point 50.57
Last Price 49.78
1st Support Level 48.64
2nd Support Level 47.51
3rd Support Level 46.71

See More

52-Week High 65.92
Fibonacci 61.8% 54.71
Fibonacci 50% 51.24
Last Price 49.78
Fibonacci 38.2% 47.78
52-Week Low 36.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar